Exploring the Anti‐Cancer Properties of Efavirenz, in Comparison to Thalidomide

Autor:	Clement Penny, Rosie Thecla McNeil
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty Efavirenz business.industry Cancer medicine.disease Biochemistry Thalidomide chemistry.chemical_compound chemistry Internal medicine Genetics Medicine business Molecular Biology Biotechnology medicine.drug
Zdroj:	The FASEB Journal. 34:1-1
ISSN:	1530-6860 0892-6638
DOI:	10.1096/fasebj.2020.34.s1.07542
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e70163090f944bb16db134221f2a4ec8 https://doi.org/10.1096/fasebj.2020.34.s1.07542 Zobrazit plný text záznamu Plný text